Bioregenx (BRGX) Invested Capital (2021 - 2025)
Bioregenx (BRGX) has 5 years of Invested Capital data on record, last reported at -$3.6 million in Q3 2025.
- For Q3 2025, Invested Capital fell 125.26% year-over-year to -$3.6 million; the TTM value through Sep 2025 reached -$3.6 million, down 125.26%, while the annual FY2024 figure was -$2.2 million, 45.0% down from the prior year.
- Invested Capital reached -$3.6 million in Q3 2025 per BRGX's latest filing, roughly flat from -$3.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $15.1 million in Q1 2024 and bottomed at -$3.7 million in Q2 2025.
- Average Invested Capital over 5 years is $1.3 million, with a median of -$1.9 million recorded in 2023.
- Peak YoY movement for Invested Capital: crashed 2110.9% in 2022, then skyrocketed 780.98% in 2024.
- A 5-year view of Invested Capital shows it stood at $115766.0 in 2021, then plummeted by 2110.9% to -$2.3 million in 2022, then skyrocketed by 33.6% to -$1.5 million in 2023, then tumbled by 45.0% to -$2.2 million in 2024, then crashed by 62.72% to -$3.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were -$3.6 million in Q3 2025, -$3.7 million in Q2 2025, and -$2.4 million in Q1 2025.